Montelukast Prescribing at PENROSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
540
Total Quantity
14.9K
NHS Cost
£754
vs National Avg
-21.1%
PENROSE SURGERY prescribed 540 items of Montelukast over the last 12 months at a cost of £754 to the NHS. This is 21.1% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
46
Jul 2026
35
Jul 2026
60
Jul 2026
41
Jul 2026
35
Jul 2026
50
Jul 2026
46
Jul 2026
52
Jul 2026
46
Jul 2026
42
Jul 2026
58
Jul 2026
29
Prescribing Details
| Total Items | 540 |
|---|---|
| Total Quantity | 14,880 |
| Total NHS Cost | £754 |
| Presentations | 4 different forms |
| vs National Average | -21.1% |
Montelukast Prescribing Comparison
| This practice | 540 items |
|---|---|
| National average per practice | 685 items |
| Difference | -21.1% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.